Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 3.57%-651.94K | -66.18%-2.42M | -192.24%-683.11K | 0.31%-713.46K | 12.91%-345.51K | -520.24%-676.05K | 40.76%-1.46M | 46.65%-233.75K | 0.15%-715.71K | 54.69%-396.71K |
| Net income from continuing operations | 75.57%-239.69K | -24.47%-2.92M | 48.93%-654.08K | -7,794.09%-658.05K | 23.31%-631.22K | -313.30%-981.14K | 5.51%-2.35M | -161.39%-1.28M | 98.51%-8.34K | 15.72%-823.06K |
| Operating gains losses | -248.21%-332 | -98.82%53 | --888 | --0 | ---1.06K | --224 | 1,180.05%4.49K | ---- | ---- | ---- |
| Asset impairment expenditure | ---- | --0 | ---- | ---- | ---- | ---- | --262.49K | ---- | ---- | ---- |
| Remuneration paid in stock | 8.08%141.87K | 33.43%723.23K | -31.95%145.76K | 188.21%314.95K | 20.12%131.26K | 20.12%131.26K | -45.96%542.02K | 25.48%214.18K | -67.65%109.28K | -53.23%109.28K |
| Change In working capital | -418.99%-553.79K | -353.96%-216.92K | -131.04%-175.68K | 54.65%-370.36K | -50.95%155.51K | 808.17%173.61K | 108.78%85.42K | 574.86%565.89K | -64.36%-816.65K | 338.93%317.07K |
| -Change in receivables | -276.97%-351.94K | 12.08%-291.35K | -235.64%-263.71K | -30.30%-236.75K | 103.92%10.25K | 339.77%198.87K | 72.82%-331.38K | 205.91%194.42K | 58.10%-181.7K | 23.66%-261.16K |
| -Change in prepaid assets | -775.07%-27.3K | -127.12%-25.98K | -116.66%-9.55K | 79.62%-15.35K | -104.50%-5.12K | --4.04K | 168.24%95.8K | -15.32%57.35K | -115.43%-75.32K | 167.98%113.78K |
| -Change in payables and accrued expense | -495.53%-174.54K | 248.60%100.4K | -68.93%97.59K | 78.87%-118.26K | 98.16%150.38K | -128.72%-29.31K | -132.01%-67.57K | 9,535.96%314.12K | -1,876.66%-559.63K | -54.54%75.89K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | --388.56K | --0 | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 3.57%-651.94K | -66.18%-2.42M | -192.24%-683.11K | 0.31%-713.46K | 12.91%-345.51K | -520.24%-676.05K | 40.76%-1.46M | 46.65%-233.75K | 0.15%-715.71K | 54.69%-396.71K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 30.10%-1.24M | 1.85%-5.28M | 20.03%-1.01M | -119.18%-1.69M | 57.17%-810.46K | -21.73%-1.78M | 18.64%-5.38M | 7.29%-1.26M | 53.52%-769.68K | -7.37%-1.89M |
| Net PPE purchase and sale | ---2.25K | -306.62%-2.15K | ---- | ---- | ---- | --0 | 99.04%-529 | 92.90%-529 | ---- | ---- |
| Net other investing changes | 30.23%-1.24M | 1.88%-5.28M | 20.16%-1.01M | -119.18%-1.69M | 57.17%-810.46K | -21.73%-1.78M | 17.97%-5.38M | 6.82%-1.26M | 53.52%-769.68K | ---1.89M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 30.10%-1.24M | 1.85%-5.28M | 20.03%-1.01M | -119.18%-1.69M | 57.17%-810.46K | -21.73%-1.78M | 18.64%-5.38M | 7.29%-1.26M | 53.52%-769.68K | -7.37%-1.89M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -98.80%38.11K | 773.01%22.19M | 516.64%15.67M | 3.05M | 286.79K | 3.18M | 36.95%2.54M | 2.54M | 0 | 0 |
| Net common stock issuance | --0 | 747.20%21.53M | 506.81%15.42M | --3.05M | --108.14K | --2.95M | 36.95%2.54M | --2.54M | --0 | --0 |
| Proceeds from stock option exercised by employees | -83.23%38.11K | --655.92K | --250K | --1 | --178.65K | --227.27K | --0 | --0 | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -98.80%38.11K | 773.01%22.19M | 516.64%15.67M | --3.05M | --286.79K | --3.18M | 36.95%2.54M | --2.54M | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 5,448.67%14.75M | -94.18%265.83K | 198.74%770.47K | -83.32%117.61K | -67.04%986.78K | -94.18%265.83K | -61.26%4.56M | -112.26%-780.33K | -91.93%705.06K | -73.67%2.99M |
| Current changes in cash | -357.56%-1.86M | 436.98%14.48M | 1,236.29%13.98M | 143.95%652.86K | 62.03%-869.18K | 145.92%720.95K | 40.46%-4.3M | 158.15%1.05M | 37.40%-1.49M | 13.23%-2.29M |
| End cash Position | 1,206.61%12.89M | 5,448.67%14.75M | 5,448.67%14.75M | 198.74%770.47K | -83.32%117.61K | -67.04%986.78K | -94.18%265.83K | -94.18%265.83K | -112.26%-780.33K | -91.93%705.06K |
| Free cash from | 3.23%-654.19K | -66.26%-2.42M | -192.50%-685.26K | 0.31%-713.46K | 12.91%-345.51K | -520.24%-676.05K | 42.03%-1.46M | 47.42%-234.27K | 0.15%-715.71K | -143.30%-396.71K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.